Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
J Neurosci Methods. 2010 Jul 15;190(2):171-9. doi: 10.1016/j.jneumeth.2010.05.001. Epub 2010 May 7.

An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies.

Author information

  • 1Interdepartmental Graduate Program in Neuroscience, Rochester, NY 14642, USA.


Soluble Abeta oligomers are recognized as playing a key role in Alzheimer's disease (AD) pathophysiology. Despite their significance, many investigators encounter difficulty generating reliable preparations for in vitro and in vivo experiments. Solutions of Abeta are often unstable and soluble conformer profiles inconsistent. In this study we describe detailed methods for preparing Abeta oligomers that are stable for several weeks and are enriched for low and high molecular weight oligomeric forms, including the 56-kDa form, a conformer implicated in AD-related cognitive impairment. We characterize their structural and functional properties using Western blot, dot blot, atomic force microscopy, Thioflavine T fluorescence, and primary neuronal culture toxicity assays. These synthetic preparations should prove valuable to many studying Abeta-mediated mechanisms underlying AD.

Copyright 2010 Elsevier B.V. All rights reserved.

[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk